RBC Capital Maintains Outperform on Medpace Holdings, Lowers Price Target to $484
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and lowers the price target from $522 to $484.
RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and lowers the price target from $522 to $484.